Evidence map›Paper›PMID 37733726›Full record

SynthesisPloS one2023

Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data.

Eman Ali, Asim Shaikh, Farah Yasmin, Fatima Sughra, Ayesha Sheikh, Rabia Owais, Hamna Raheel, Hafeez Ul Hassan Virk, Jihad A Mustapha

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Mechanisms Linking Insomnia and Cardiometabolic Disease Risk.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Eman AliDow Medical College, Dow University of Health Sciences, Karachi, Pakistan.ORCID 0000-0002-2977-0741
Asim ShaikhAga Khan University Hospital, Karachi, Pakistan.
Farah YasminYale University School of Medicine, New Haven, CT, United States of America.
Fatima SughraDow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Ayesha SheikhDow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Rabia OwaisDow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Hamna RaheelDow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Hafeez Ul Hassan VirkAdena Regional Medical Center, Chillicothe, OH, United States of America.
Jihad A MustaphaMichigan State University College of Human Medicine, Grand Rapids, MI, United States of America.
Dow University of Health Sciences · PKAdena Regional Medical Center · USAga Khan University Hospital · PKGrand Rapids Community College · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insomnia is a prevalent sleeping disorder associated with increasing cardiovascular (CV) mortality and morbidity. However, data incorporating recent clinical studies evaluating these outcomes is scarce. Hence, we aimed to investigate the association of insomnia with CV mortality, myocardial infarction (MI), all-cause mortality, and incidence of CV disease by conducting the first-ever meta-analysis of real-world data evaluating these CV outcomes. MEDLINE and Scopus databases were queried till August 2022 to identify studies comparing prespecified outcomes in patients with and without insomnia. The primary outcomes were CV mortality and myocardial infarction, while secondary outcomes included all-cause mortality, and CV-disease incidence. All data were pooled using an inverse-variance weighted random-effects model, and results were reported as relative risks (RRs) and p-values. 21 studies were analyzed. Risks for CV mortality and MI were significantly higher in patients with insomnia (RR 1.53, p<0.01, and RR 1.48, p = 0.03, respectively). The risk for all-cause mortality and CV disease incidence was also significantly higher in insomnia patients (RR 1.14, p = 0.03, and RR 1.31, p<0.01, respectively). Individuals with insomnia experience a higher risk of long-term mortality, MI, and incidence of CV disease.

Indexed as

Cardiovascular SystemMyocardial InfarctionSleep Initiation and Maintenance DisordersHumansIncidenceSleep

Identifiers

PMID37733726
PMCPMC10513332
OpenAlexW4386918208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.